How Is Colgate-Palmolive’s Revenue and EBITDA Composition Expected To Change In The Future?

-10.23%
Downside
89.99
Market
80.78
Trefis
CL: Colgate Palmolive logo
CL
Colgate Palmolive

  • Oral Care’s revenue and EBITDA share is likely to increase sharply as its growth will outpace other segments.
  • Colgate-Palmolive’s return of focus to its primary strength, Oral Care, could reduce its presence in Personal Care and Home Care

CL 6

Have more questions on Colgate-Palmolive (NYSE:CL)? See the links below:

Relevant Articles
  1. Should You Pick Colgate-Palmolive Stock Over Monster Beverage After The Latter’s 2x Gains This Year?
  2. Should You Pick Colgate-Palmolive Stock After A Q3 Beat And 4% Gains This Month?
  3. Is Colgate-Palmolive Stock A Better Pick Over Marriott?
  4. Which Is A Better Consumer Defensive Pick – Kimberly-Clark Or CL Stock?
  5. Should You Buy Colgate-Palmolive Stock At $80?
  6. Should You Buy This Households & Personal Products Company Over Colgate-Palmolive Stock?

Notes:

1) The purpose of these analyses is to help readers focus on a few important things. We hope such lean communication sparks thinking, and encourages readers to comment and ask questions on the comment section, or email content@trefis.com
2) Figures mentioned are approximate values to help our readers remember the key concepts more intuitively. For precise figures, please refer to our complete analysis for Colgate-Palmolive

Get Trefis Technology